array(1) {
  [0]=>
  object(Apache_Solr_Document)#24 (3) {
    ["_documentBoost":protected]=>
    bool(false)
    ["_fields":protected]=>
    array(6) {
      ["content_id"]=>
      array(1) {
        [0]=>
        string(14) "DIRECTORY_4565"
      }
      ["content_title"]=>
      array(1) {
        [0]=>
        string(21) "NICOLA BIAGIO MERCURI"
      }
      ["description"]=>
      array(1) {
        [0]=>
        string(18402) "<document><p>
	ESPERIENZA ACCADEMICA ED INCARICHI ASSISTENZIALI</p>
<p>
	&bull; Data (dal 2009 ad oggi) Professore Ordinario, disciplina Neurologia</p>
<p>
	&nbsp;&nbsp; Datore di lavoro &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Universit&agrave; degli studi di Roma Tor Vergata</p>
<p>
	&bull; Tipo di azienda o settore Policlinico Tor Vergata</p>
<p>
	Dal 2018 ad oggi&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Senatore Accademico</p>
<p>
	Impiego dal 2011 ad&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dirigente di secondo livello U.O.C.di Neurofisiopatologia</p>
<p>
	Ottobre 2015)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<p>
	&bull; Da Novembre 2015 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dirigente di secondo livello U.O.C.di Neurologia</p>
<p>
	&bull; Dal 2005 al 2008 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Professore Associato, disciplina Neurologia</p>
<p>
	&bull; Dal 1987 al 2005&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tecnico laureato presso la Clinica Neurologica Tor Vergata</p>
<p>
	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; all&rsquo;Ospedale Sant&rsquo;Eugenio (1997-2000) e PTV (2000-2005)</p>
<p>
	&nbsp;</p>
<p class="totem_indent">
	&nbsp;</p>
<p>
	ATTIVITA&rsquo; DI RICERCA</p>
<p>
	&bull;&nbsp;&nbsp;Dal 1996 al 2017 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Direttore dei Laboratori di Neurologia Sperimentale</p>
<p class="totem_indent">
	pressoI.R.C.C.S Santa Lucia, Roma nell&rsquo;ambito di una convenzione&nbsp; con l&rsquo;Universit&agrave; di Tor Vergata,</p>
<p>
	&bull;&nbsp;&nbsp;Dal 2018 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Direttore della linea di ricerca di base&nbsp;</p>
<p>
	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<p>
	&bull; Dal 2005 al 2008&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Membro dello Scientific Advisory Group on Central</p>
<p>
	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nervous System (SAG-CNS) group of European Medicines Agency (EMEA)</p>
<p>
	&nbsp;</p>
<p>
	&bull; nel 1990 e 1993&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ricercatorepresso il Vollum Institute</p>
<p>
	2 periodi di 3 mesi&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Health Sciences University, Portland-Oregon US A</p>
<p>
	&nbsp;</p>
<p>
	&bull;Dal 1985 al 1986 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ricercatore / Visiting Scientist Presso il Massachusetts</p>
<p>
	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Institute of Technology, Cambridge (USA)</p>
<p>
	&bull; Dal 1983 al 1984 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ricercatore e medico borsista CNR presso la Clinica</p>
<p>
	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;Neurologica Universit&agrave; degli Studi di Roma La Sapienza</p>
<p>
	&nbsp;</p>
<p>
	&bull;&nbsp;Nel 1982&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ricercatore/ Post Doctoral FellowPresso il Dipartimento di &nbsp;</p>
<p>
	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Neurofarmacologia del Max Planck Institute per la Psichiatria</p>
<p>
	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; di &nbsp;Monaco di Baviera</p>
<p>
	&nbsp;</p>
<p>
	ISTRUZIONE E FORMAZIONE</p>
<p>
	&bull; dal 1973 al 1979 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Corso di Medicina e Chirurgia presso Universit&agrave; degli studi di</p>
<p>
	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Roma La Sapienza</p>
<p>
	&bull; nel 1979&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Medico-Chirurgo</p>
<p>
	&bull; dal 1979 &ndash; al 1983&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Corso di specializzazione in Neurologia e</p>
<p>
	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Specializzazione conseguita bel 1983 presso L&rsquo;Universit&agrave;</p>
<p>
	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;degli studi di Roma &ldquo;La Sapienza&rdquo;</p>
<p>
	&nbsp;</p>
<p>
	PRIMA LINGUA ITALIANO</p>
<p>
	ALTRE LINGUE INGLESE</p>
<p>
	&bull; Capacit&agrave; di lettura &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;Ottima</p>
<p>
	&bull; Capacit&agrave; di scrittura&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ottima</p>
<p>
	&bull; Capacit&agrave; di espressione Ottima</p>
<p>
	&nbsp;</p>
<p>
	ATTIVIT&Agrave; ASSISTENZIALE</p>
<p>
	L&rsquo;attivita&rsquo; Clinica del prof Mercuri &egrave; stata sempre caratterizzata da un contatto diretto con il paziente. Nelle prime fasi della sua carriera di Neurologo ha svolto attivit&agrave; ambulatoriale e di reparto. Ha anche svolto attivit&agrave; di guardia neurologica diurna e notturna, e accertamento di morte cerebrale, sia presso l&rsquo;Ospedale S. Eugenio</p>
<p>
	che presso il PTV. Con la venuta al PTV nel 2000, l&rsquo;attivit&agrave; clinica si &egrave; poi principalmente incentrata sull&rsquo;attivit&agrave; di Reparto, dove egli ha svolto, fino al 2012, data di trasferimento dalla Neurologia alla Neurofisiopatologia il ruolo di caporeparto.</p>
<p>
	Dal 2012 ad Ottobre 2015, ha diretto la UOC di Neurofisiopatologia. Presso tale UOC ha anche messo in atto un percorso ambulatoriale/assistenziale per i pazienti affetti dalla debilitante malattia neurologica rappresentata dalla Sclerosi Laterale</p>
<p>
	Amiotrofica.</p>
<p>
	Da Novembre 2015 ad oggi, egli dirige le UOC di Neurologia. Da Ottobre 2023 Direttore di dipartimento clinico f.f.</p>
<p>
	&nbsp;</p>
<p>
	ATTIVITA&rsquo; SCIENTIFICA</p>
<p>
	Il Prof. Mercuri si interessa principalmente dello studio di malattie neurodegenerative (morbo di Parkinson, morbo di Huntington, Alzheimer e sclerosi laterale amiotrofica), dei fenomeni di base che sottendono l&rsquo;epilessia e delle risposte cellulari alla deprivazione energetica, nonch&eacute; del meccanismo d&rsquo;azione dei farmaci antiepilettici e neuroprotettivi.</p>
<p>
	La sua attivit&agrave; di ricerca &egrave; inoltre incentrata sul meccanismo d&rsquo;azione delle sostanze d&rsquo;abuso e degli antidepressivi.</p>
<p>
	&nbsp;</p>
<p>
	ATTIVITA&rsquo; DIDATTICA</p>
<p>
	Dal 2009 al 2015, &egrave; stato Titolare dell&rsquo;insegnamento di Neuropsichiatria presso il corso di laurea in Scienze della Nutrizione Umana.</p>
<p>
	Dal 2015 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Coordinatore/Titolare del Corso di Laurea per Medicina, in Scienze &nbsp;&nbsp;</p>
<p>
	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Neurologiche.</p>
<p>
	Insegna alla scuola di specializzazione in Neurologia e Medicina Interna</p>
<p>
	Dal 2012 al 2018&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Coordinatore del corso di dottorato in Neuroscienze.</p>
<p>
	Dal 2015 al 2028&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Presidente del Corso di Laurea in Fisiochinesiterapia.</p>
<p>
	Dal 2018 ad oggi&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Direttore della scuola di specializzazione in neurologia</p>
<p>
	&nbsp;</p>
<p>
	PUBBLICAZIONI SCIENTIFICHE</p>
<p>
	E&rsquo; autore di pubblicazioni in lingua straniera (inglese) con referees e indicizzate, di capitoli su libri in Inglese ed in Italiano.</p>
<p>
	E' referee di accreditate riviste scientifiche internazionali quali:</p>
<p>
	(Neuroscience, J. Neurophysiology, Neuropharmacology, Brain Research, Neuropsychopharmacology, Synapse, J. Physiology, JPET, J. Neuroscience, Movement Disorders; etc.), e' inoltre referee di grants nazionali ed internazionali.</p>
<p>
	E&rsquo; nell&rsquo;editorial board di Functional Neurology e Frontiers in Neuroscience.</p>
<p>
	Le ricerche del prof. Mercuri sono state principalmente finanziate dal Ministero della Salute e dal MIUR (&egrave; stato detentore di Finanziamenti: FIRB eCofin).</p>
<p>
	Inoltre ha recentemente ottenuto un grant da un consorzio internazionale (ASAP -) per lo studio degli effetti della neuromelanina in modelli animali di Parkinson.</p>
<p>
	Ha ottenuto un Finanziamento PNRR per lo studio della neuroinfiammazione nelle malattie degenerative.</p>
<p>
	E&rsquo; referente operativo unico di tutti gli spoke del progetto di Partenariato Esteso 12 "A Multiscale integrated approach to the study of the nervous system in health and disease (MNESYS)"</p>
<p>
	&nbsp;</p>
<p>
	Ha un total h-index su Scopus di 67</p>
<p>
	&nbsp;</p>
<p>
	AFFILIAZIONI</p>
<p>
	Dal 1984 - &nbsp;&nbsp; Membro, International Basal Ganglia Society.</p>
<p>
	Dal 1984 - &nbsp;&nbsp; Membro, European Neuroscience Association.</p>
<p>
	Dal 1986 - &nbsp;&nbsp; Membro, Societa' per i disturbi del movimento.</p>
<p>
	Dal 1987 - &nbsp;&nbsp; Membro dell'IBRO.</p>
<p>
	Dal 1989 - &nbsp;&nbsp; Membro della Societa' Italiana di Neurologia.</p>
<p>
	Dal 1990 - &nbsp;&nbsp; Membro della Societa' Italiana di Neuroscienze.</p>
<p>
	Dal 1995- &nbsp;&nbsp;&nbsp; Membro dell'American Neuroscience Association</p></document><document><p>
	include postdoctoral training and residency training if applicable. Add/delete rows as necessary.)</p>

	
		
			
				<p>
					INSTITUTION AND LOCATION</p>
			
			
				<p>
					DEGREE</p>
				<p>
					(if applicable)</p>
				<p>
					&nbsp;</p>
			
			
				<p>
					Completion Date</p>
				<p>
					MM/YYYY</p>
				<p>
					&nbsp;</p>
			
			
				<p>
					FIELD OF STUDY</p>
				<p>
					&nbsp;</p>
			
		
	
	
		
			
				<p>
					University of Rome, La Sapienza</p>
			
			
				<p>
					MD</p>
			
			
				<p>
					07/1979</p>
			
			
				<p>
					Medicine</p>
			
		
		
			
				<p>
					University of Rome, La Sapienza</p>
			
			
				<p>
					Specialist</p>
			
			
				<p>
					12/1982</p>
			
			
				<p>
					Neurology</p>
			
		
		
			
				<p>
					Max Planck Institute Munich German</p>
			
			
				<p>
					Post Doc</p>
			
			
				<p>
					01/1982</p>
			
			
				<p>
					Neuropharmacology</p>
			
		
		
			
				<p>
					MIT Cambridge MA, (USA</p>
			
			
				<p>
					Scientist</p>
			
			
				<p>
					12/1987</p>
			
			
				<p>
					Neuropharmacology</p>
			
		
		
			
				<p>
					&nbsp;</p>
			
			
				<p>
					&nbsp;</p>
			
			
				<p>
					&nbsp;</p>
			
			
				<p>
					&nbsp;</p>
			
		
	

<p>
	&nbsp;</p>
<p>
	&nbsp;</p>
<p>
	A. Personal statement</p>
<p>
	&nbsp;</p>
<p>
	I am the Director of the Department of mental and neurological, dental and sensory organ health well-being, at the University Hospital. I am the Director of the School of Neurology at the Tor Vergata University in Rome and the Director of the Neurological Clinic in the University Hospital. I am the Director of the Experimental Neurology laboratories at the IRCCS Fondazione Santa Lucia in Rome, Italy.</p>
<p>
	My research interest has been mainly devoted to understanding the effects of DA and dopaminergic drugs in the brain. I have particular experience in neuronal electrophysiology and pharmacology; Receptor- and voltage-operated ionic conductances; Mechanisms of synaptic transmission; Actions of psychoactive drugs and neurohormones.</p>
<p>
	I have good clinical experience in dealing with movement and other neurological disorders.</p>
<p>
	I have presented and disseminated my work in several national and international congresses.</p>
<p>
	&nbsp;</p>
<p>
	&nbsp;</p>
<p>
	I have published more than 558 papers in peer reviewed neuroscience journals and several chapters in books.&nbsp;</p>
<p>
	&nbsp;</p>
<p>
	My H index is 67 (Scopus) and 78 (Google scholar)</p>
<p>
	&nbsp;</p>
<p>
	ORCID - </p>
<p>
	https://orcid.org/0000-0001-6700-7491</p>
<p>
	&nbsp;</p>
<p>
	B.Positions and Honors</p>
<p>
	&nbsp;</p>
<p>
	B.1 Positions </p>
<p>
	
	1987-2000. Assistant of Neurology, University of Rome, Tor Vergata&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<p>
	&nbsp;</p>
<p>
	1996-2023.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Director of Basic Research, IRCCS Santa Lucia Foundation &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;</p>
<p>
	&nbsp;</p>
<p>
	2000-2005. Associate Prof of Neurology, University of Rome, Tor Vergata&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<p>
	&nbsp;</p>
<p>
	2005-present. &nbsp;Full Prof of Neurology, University of Rome, Tor Vergata</p>
<p>
	&nbsp;</p>
<p>
	2024-present. Director of the Department of mental and neurological, dental and sensory organ health well-being</p>
<p>
	&nbsp;</p>
<p>
	B.2 Honors </p>
<p>
	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

	
		
			
				<ul>
					<li>
						Member of the Scientific Advisory Group on Central Nervous System (SAG-CNS) group European Medicines Agency (EMEA), London.</li>
					<li>
						Member of the following associations: International Basal Ganglia Society, European Neuroscience Association, IBRO, Movement disorders Society, Italian Neurology Society, Italian Neuroscience Society</li>
					<li>
						Chair of the Basic Science Tutorial in the International Basal Ganglia Society&nbsp; Meeting (Merida, 2017) and Dopamine Receptors Symposium (Vienna, 2016)</li>
					<li>
						Invited speaker at more than 50 national and international congresses</li>
					<li>
						Director of the Operative Unit of Neurology of Tor Vergata University</li>
					<li>
						Director of Basic Neuroscience Research at IRCCS Santa Lucia</li>
					<li>
						Member of the National Committee for studying the chemical, pharmacological and toxicological aspects of drug of abuse. Italian Minister of Health.</li>
					<li>
						Novartis Award for Neuroscience (1996)</li>
					<li>
						Winner of the Deutsche Forshungsgeimenshaft in Max Planck (1982)</li>
				</ul>
			
		
		
			
				<p>
					&nbsp;</p>
			
		
		
			
				<p>
					&nbsp;</p>
			
		
	

<p>
	C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Contributions to Science
	</p>
<p>
	On a scientific level, I am mainly dedicated to the study of the physiopathology and pharmacology of substantia nigra pars compacta and ventral tegmental neurons. This has implications in neurodegenerative diseases (Parkinson's disease, Huntington's disease, and Alzheimer's). I have been also interested to the basic phenomena underlying sleep disorders, epilepsy and the cellular responses to energy deprivation, as well as, to the mechanism of action of antiepileptic and neuroprotective drugs. I am also interested in the mechanism of action of substances of abuse and antidepressants. My research activity led to more than 555 papers in peer-reviewed journals in the field of neuroscience.&nbsp;</p></document> a:0:{}"
      }
      ["meta_keywords"]=>
      array(1) {
        [0]=>
        string(1) ","
      }
      ["reserved"]=>
      array(1) {
        [0]=>
        string(1) "0"
      }
      ["auth_ip"]=>
      array(1) {
        [0]=>
        string(1) "0"
      }
    }
    ["_fieldBoosts":protected]=>
    array(6) {
      ["content_id"]=>
      bool(false)
      ["content_title"]=>
      bool(false)
      ["description"]=>
      bool(false)
      ["meta_keywords"]=>
      bool(false)
      ["reserved"]=>
      bool(false)
      ["auth_ip"]=>
      bool(false)
    }
  }
}